D. Medical, a medical device company that develops and manufactures insulin pumps, filed on Tuesday with the SEC to raise up to $30 million in an initial public offering. The Israel-based company, which was founded in 1992 but has yet to book material sales, plans to list on the NASDAQ under the symbol DMED. Its shares are currently traded on the Tel-Aviv stock exchange under the ticker DMDC. Rodman & Renshaw and ThinkEquity are the lead underwriters on the deal. No pricing terms were disclosed.
